Nagy, A et al. applied ddPCR to analyse the mutation and prognostic value of EZH2 in plasma samples from 4 patients with FL (Nagy et al., 2020), and Shin, S et al. discovered CREBBP mutations in plasma cfDNA using targeted deep sequencing in two follicular lymphoma patients. This evidence concerns the gene EZH2 and follicular lymphoma.